(1 - 11 von 19
)
Phase III results: Once daily olodaterol* Respimat provides effective...
www.finanznachrichten.de
Professor Klaus Dugi, Corporate Senior Vice President Medicine, Boehringer Ingelheim (Photo: Business Wire). For media outside the UK, U.S. ...
Boehringer Ingelheim and CureVac announce collaboration to develop...
www.bionity.com
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy in lung cancer,” said Professor Klaus Dugi, ...
Boehringer forscht mit an Impfstoff gegen Lungenkrebs
www.schwaebische.de
... anhaltenden Aktivierung des Immunsystems gegen den Tumor“, sagt Professor Klaus Dugi, Chief Medical Officer bei Boehringer Ingelheim.
FDA Approves TWYNSTA (telmisartan plus amlodipine) a New Single Pill...
www.finanznachrichten.de
Professor Klaus Dugi, Corporate Vice President Medical Affairs, Boehringer Ingelheim, commented, ”We are delighted with the approval of TWYNSTA® and believe ...
sortiert nach Relevanz / Datum